Answers are grounded in this paper and cite their sources.
Complex and overlapping clinical presentation of systemic autoimmune diseases, such as Psoriatic arthritis (PsA) and Rheumatoid arthritis (RA), creates significant difficulties in early diagnosis and management. Metabolomics, as a rapidly developing field, holds a great potential to identify the intricate metabolic disturbances related to these conditions. This may assist in the early and accurate diagnosis, and personally-tailored treatment of these conditions.
No takes yet. Share an insight, caveat, or question.
Koteswari Peddi (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: